Synergy of HDACi, PARPi and Chemotherapeutics Against Blood Cancer
Researchers investigated the efficacy of HDAC inhibitors in combination with PARP inhibitors and chemotherapeutic drugs... read more
October 19, 2022
Tagged: lymphoma
Epigenetics and Immunotherapy Combined Fights Rare Lymphoma
In a new Oncotarget study, researchers assessed an epigenetic and immunotherapy treatment regimen among patients... read more
August 24, 2022
Trending With Impact: Dual Requirement in Stem Cell Leukemia/Lymphoma
For the first time, researchers revealed the protein interactome, phospho-proteome and total proteome for the... read more
May 12, 2022
Trending with Impact: RNA-Seq Analyses Show Targets in B-cell Lymphoma
The current study is the first of its kind, wherein comprehensive transcriptome analysis using RNA-Seq... read more
January 14, 2021
MRI and ADC Histogram Analysis in Lymphoma Treatment
Scientists have long been aware that lymphoma occurs when multiple genetic changes take place in... read more
November 10, 2020
New Synergistic Method of Treatment for Select Lymphomas
A team of scientists from Columbia University Medical Center has formulated a new, synergistic method... read more
September 29, 2020